A isoforms. Neuron 2004, 43:333?44. 66. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Like S: A-degrading enzymes in Alzheimer’s disease. Brain Pathol 2008, 18:240?52. 67. Nagara H, Suzuki K: Chronological study of oligodendroglial alterations and myelination in quaking mice. Neuropathol Appl Neurobiol 1981, 7:135?49. 68. Finest TT, Skoff RP, Bartlett WP: Astroglial plasticity in hemizygous and heterozygous jimpy mice. Int J Dev Neurosci 1988, six:39?7. 69. Dyer CA, Kendler A, Jean-Guillaume D, Awatramani R, Lee A, Mason LM, Kamholz J: GFAP-positive and myelin marker-positive glia in normal and pathologic environments. J Neurosci Res 2000, 60:412?26. 70. Maeda A, Sobel RA: Matrix metalloproteinases inside the standard human central nervous technique, microglial nodules, and several sclerosis lesions. J Neuropathol Exp Neurol 1996, 55:300?09. 71. Liuzzi GM, Latronico T, Fasano A, Carlone G, Riccio P: Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for a number of sclerosis pathogenesis and remedy. Mult Scler 2004, 10:290?97. 72. del Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Berg GI, Koziol JA: Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007, 38:646?51. 73. del Zoppo GJ, Frankowski H, Gu YH, Osada T, Kanazawa M, Milner R, Wang X, Hosomi N, Mabuchi T, Koziol JA: Microglial cell activation is really a source of metalloproteinase generation during hemorrhagic transformation. J Cereb Blood Flow Metab 2012, 32:919?32. 74. Roher AE, Kasunic TC, Woods AS, Cotter RJ, Ball MJ, Fridman R: Proteolysis of A peptide from Alzheimer illness brain by gelatinase A. Biochem Biophys Res Commun 1994, 205:1755?761. 75. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA: Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons in the human hippocampus and is capable of degrading the amyloid- peptide (1?0).Formula of 197632-76-1 J Neurosci 1996, 16:7910?919.28048-17-1 manufacturer 76. Yan P, Hu X, Song H, Yin K, Bateman RJ, Cirrito JR, Xiao Q, Hsu FF, Turk JW, Xu J, Hsu CY, Holtzman DM, Lee JM: Matrix metalloproteinase-9 degrades amyloid- fibrils in vitro and compact plaques in situ.PMID:23695992 J Biol Chem 2006, 281:24566?4574. 77. Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H, Hsu FF, Turk J, Xu J, Hsu CY, Mills JC, Holtzman DM, Lee JM: Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid- peptide catabolism. J Neurosci 2006, 26:10939?0948. 78. White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE, Holsinger RM, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI,Ou-Yang and Van Nostrand Journal of Neuroinflammation 2013, 10:134 http://jneuroinflammation/content/10/1/Page 12 ofMasters CL: Degradation on the Alzheimer disease amyloid -peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 2006, 281:17670?7680. 79. Kotarba AE, Aucoin DS, Hoos MD, Smith SO, Van Nostrand WE: Fine mapping in the amyloid ss-protein binding web site on myelin basic protein. Biochemistry 2013, 52(15):2565?573.doi:ten.1186/1742-2094-10-134 Cite this article as: Ou-Yang and Van Nostrand: The absence of myelin basic protein promotes neuroinflammation and reduces amyloid -protein accumulation in Tg-5xFAD mice. Journal of Neuroinflammation 2013 10:134.Submit your subsequent manuscript to BioMed Central and take complete advantage of:?Convenient on-line submission ?Thorough peer evaluation ?No space constraints or color figure charges ?Quick publication on acceptance ?Inclusio.